Associated Papers
Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival.
Osumi H et al.
Molecular and Clinical Oncology, 2015
Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study.
Yoshino T et al.
Ebiomedicine, 2015
Select a paper to view details